🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

GRANULES vs THEMISMED: Stock Comparison

GRANULES INDIA vs THEMIS MEDICAREUpdated 30 Oct 26, 11:07 AM ISTNSE & company filings

GRANULES INDIA is the larger company by market capitalisation. GRANULES INDIA shows a higher ROE, faster revenue growth and lower leverage, while THEMIS MEDICARE shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GRANULES leads 8; THEMISMED leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GRANULESTHEMISMED

Valuation lens

What price are you paying?

Market CapContext only
₹23,283 Cr
₹910 Cr
P/E RatioTHEMISMED has the lower reading
31.22x
22.24x ✓
P/B RatioTHEMISMED has the lower reading
4.1x
2.23x ✓
EPSGRANULES has the higher reading
₹26.92 ✓
₹2.67
Book ValueContext only
₹205.21
₹43.28
Dividend YieldTHEMISMED has the higher reading
0.21%
0.52% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GRANULES is the larger company
₹23,283 Cr vs ₹910 Cr
P/E Ratio
THEMISMED has a lower P/E
22.24x vs 31.22x
P/B Ratio
THEMISMED has a lower P/B
2.23x vs 4.1x
EPS
GRANULES has higher earnings per share
₹26.92 vs ₹2.67
Dividend Yield
THEMISMED has a higher dividend yield
0.52% vs 0.21%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs 6.7%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs 0%
ROE
GRANULES has a higher ROE
9.11% vs 0.29%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESTHEMISMED
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESTHEMISMED
Live Price₹853.95₹98.78
Day Change1.98%1.29%
Volume3.33 L15,306
52-Week High₹923.65₹140.6
52-Week Low₹529.85₹64.95
Distance from 52W High-7.55%-29.74%

Valuation

MetricGRANULESTHEMISMED
Market Cap₹23,283 Cr₹910 Cr
P/E Ratio31.22x22.24x
P/B Ratio4.1x2.23x
EPS₹26.92₹2.67
Book Value₹205.21₹43.28
Dividend Yield0.21%0.52%

Growth

MetricGRANULESTHEMISMED
Revenue Growth (TTM YoY)22.8%6.7%
EPS Growth (TTM YoY)31.3%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricGRANULESTHEMISMED
ROE9.11%0.29%
ROCE9.07%-0.27%
Net Margin11.15%0.33%
Operating Margin17.19%-0.42%
Debt to Equity0.17x0.25x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricGRANULESTHEMISMED
Promoter Holding37.08%▼ 0.59 pp57.5%
FII Holding20.25%▲ 2.75 pp0.01%
DII Holding15.33%▼ 0.78 pp0.01%
Public Holding27.04%▼ 1.34 pp32.87%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRANULES INDIA and THEMIS MEDICARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.